Julhash U. Kazi
Julhash U. Kazi
Lund University
Verified email at - Homepage
Cited by
Cited by
T cell receptor (TCR) signaling in health and disease
K Shah, A Al-Haidari, J Sun, JU Kazi
Signal transduction and targeted therapy 6 (1), 412, 2021
SYK is a critical regulator of FLT3 in acute myeloid leukemia
A Puissant, N Fenouille, G Alexe, Y Pikman, CF Bassil, S Mehta, J Du, ...
Cancer cell 25 (2), 226-242, 2014
FMS-like tyrosine kinase 3/ FLT3: from basic science to clinical implications
JU Kazi, L Rönnstrand
Physiological Reviews 99 (3), 1433–1466, 2019
Aberrant activation of the PI3K/mTOR pathway promotes resistance to sorafenib in AML
O Lindblad, E Cordero, A Puissant, L Macaulay, A Ramos, NN Kabir, ...
Oncogene 35 (39), 5119-5131, 2016
SOCS proteins in regulation of receptor tyrosine kinase signaling
JU Kazi, NN Kabir, A Flores-Morales, L Rönnstrand
Cellular and molecular life sciences 71, 3297-3310, 2014
Suppressor of cytokine signaling 6 (SOCS6) negatively regulates Flt3 signal transduction through direct binding to phosphorylated tyrosines 591 and 919 of Flt3
JU Kazi, J Sun, B Phung, F Zadjali, A Flores-Morales, L Rönnstrand
Journal of Biological Chemistry 287 (43), 36509-36517, 2012
Suppressor of cytokine signaling 2 (SOCS2) associates with FLT3 and negatively regulates downstream signaling
JU Kazi, L Rönnstrand
Molecular oncology 7 (3), 693-703, 2013
Machine learning in the prediction of cancer therapy
R Rafique, SMR Islam, JU Kazi
Computational and Structural Biotechnology Journal 19, 4003-4017, 2021
Keratin 19 expression correlates with poor prognosis in breast cancer
NN Kabir, L Rönnstrand, JU Kazi
Molecular biology reports 41, 7729-7735, 2014
The dual specificity PI3K/mTOR inhibitor PKI-587 displays efficacy against T-cell acute lymphoblastic leukemia (T-ALL)
M Gazi, SA Moharram, A Marhäll, JU Kazi
Cancer Letters 392, 9-16, 2017
FLT3 signals via the adapter protein Grb10 and overexpression of Grb10 leads to aberrant cell proliferation in acute myeloid leukemia
JU Kazi, L Rönnstrand
Molecular oncology 7 (3), 402-418, 2013
Celecoxib‐induced growth inhibition in SW480 colon cancer cells is associated with activation of protein kinase G
JW Soh, JU Kazi, H Li, WJ Thompson, IB Weinstein
Molecular Carcinogenesis: Published in cooperation with the University of …, 2008
Brain-Expressed X-linked (BEX) proteins in human cancers
JU Kazi, NN Kabir, L Rönnstrand
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1856 (2), 226-233, 2015
Adaptor protein Lnk binds to and inhibits normal and leukemic FLT3
DC Lin, T Yin, M Koren-Michowitz, LW Ding, S Gueller, S Gery, ...
Blood, The Journal of the American Society of Hematology 120 (16), 3310-3317, 2012
De novo activating mutations drive clonal evolution and enhance clonal fitness in KMT2A-rearranged leukemia
A Hyrenius-Wittsten, M Pilheden, H Sturesson, J Hansson, MP Walsh, ...
Nature Communications 9 (1), 1770, 2018
The role of HOXB2 and HOXB3 in acute myeloid leukemia
O Lindblad, RA Chougule, SA Moharram, NN Kabir, J Sun, JU Kazi, ...
Biochemical and biophysical research communications 467 (4), 742-747, 2015
Src-Like adaptor protein (SLAP) binds to the receptor tyrosine kinase Flt3 and modulates receptor stability and downstream signaling
JU Kazi, L Rönnstrand
PloS one 7 (12), e53509, 2012
SOCS6 is a selective suppressor of receptor tyrosine kinase signaling
NN Kabir, J Sun, L Rönnstrand, JU Kazi
Tumor Biology 35, 10581-10589, 2014
Isoform-specific translocation of PKC isoforms in NIH3T3 cells by TPA
JU Kazi, JW Soh
Biochemical and biophysical research communications 364 (2), 231-237, 2007
Germline mutations of KIT in gastrointestinal stromal tumor (GIST) and mastocytosis
H Ke, JU Kazi, H Zhao, J Sun
Cell & Bioscience 6, 1-10, 2016
The system can't perform the operation now. Try again later.
Articles 1–20